Prescription Drugs 2 Go

Pharmaceutical manufacturer Allergan, Inc. has agreed to pay $225 million to resolve civil allegations that it unlawfully promoted its drug Botox® Therapeutic for unapproved uses and that it paid…(PRWeb September 01, 2010)Read the full story at http://www.prweb.com/releases/2010/09/prweb4455594.htm (Source: PRWeb: Medical Pharmaceuticals)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a long federal investigation into its marketing of the top-selling, botulin-based drug. (Source: WDSU.com – Health)

Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug. (Source: CTV Health)

Allergan agreed to pay $600 million to settle criminal and civil allegations that it had marketed Botox for medical uses, like pain and headache, not approved by the Food and Drug Administration. (Source: NYT Health)

Allergan Inc., the makers of Botox (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company’s past sales and marketing practices related to specific therapeutic uses of Botox. The DOJ had alleged that the Botox maker had tried to enhance Botox sales through uses the FDA (Food and Drug Administration) had not approved. In a press release, Sally Yates, U.S… (Source: Health News …

Company Allergan Inc. Says it Will Plead Guilty to Misdemeanor Charge of “Misbranding” Botulin-Based Drug for Unapproved Uses (Source: Health News: CBSNews.com)

(MedPage Today) — Botox manufacturer Allergan will pay $375 million after pleading guilty to a misdemeanor misbranding charge related to off-label use of the cosmetic drug, a statement on the company’s website said. (Source: MedPage Today Public Health)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Company Allergan Inc. Says it Will Plead Guilty to Misdemeanor Charge of “Misbranding” Botulin-Based Drug for Unapproved Uses (Source: Health News: CBSNews.com)

Company Allergan Inc. Says it Will Plead Guilty to Misdemeanor Charge of “Misbranding” Botulin-Based Drug for Unapproved Uses (Source: Health News: CBSNews.com)

Allergan agreed to settle criminal and civil allegations that it had marketed Botox for uses not approved by the Food and Drug Administration. (Source: NYT Health)